Science 37 Holdings Inc SNCE

Science 37 Holdings, Inc. is engaged in patient-centric clinical trials and in supporting novel approaches to decentralized clinical trial designs. Through its patient-centric approach, it reduces the impact of the geographic barriers associated with conventional physical clinical trial sites, enabling recruitment of virtually any patient. Its offerings lie in its configurable unified technology platform combined with its centralized patient recruitment capabilities and specialized network of patient communities. Its unified technology platform is purpose-built for patient-centric clinical trial execution and is designed to provide an end-to-end, single stop solution. It also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, and remote coordinators designed for the purpose of orchestrating patient-centric clinical trials. It uses diversified, multi-channel programs to identify patients who fit the profile for each of its projects.

NDAQ:SNCE - Post by User

Science 37 Holdings Inc

<< Previous

Bullboard Posts

Post by whytestockson Jan 29, 2024 12:00pm

54 Views

Post# 35850577

Science 37 to be Acquired by eMed, Expanding Access to Patie

Breaking News: $SNCE Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating EnrollmentRESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading Metasite TM , today announced that it has entered into a definitive merger agre...SNCE - Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

<< Previous

Bullboard Posts

Critical materials crisis: Diversifying away from China’s monopoly